(Q44347649)

2 December 2017

Etorphines: mu-opioid receptor-selective antinociception and low physical dependence capacity (English)

1 reference

2 December 2017

0 references

1 reference

M D Aceto

1

1 reference

2 December 2017

L S Harris

series ordinal

2

1 reference

2 December 2017

E R Bowman

series ordinal

3

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 November 1997

1 reference

European Journal of Pharmacology

2 December 2017

1 reference

2 December 2017

338

1 reference

2 December 2017

3

1 reference

2 December 2017

215-223

1 reference

The Effects of Naloxone and Nalorphine during the Development of Morphine Dependence in Rhesus Monkeys

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981924-3

Caffeine elicited withdrawal signs in morphine-dependent rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981924-3

The biological, social and clinical bases of drug addiction: commentary and debate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981924-3

Novel analgesics and molecular rearrangements in the morphine-thebaine group. III. Alcohols of the 6,14-endo-ethenotetrahydrooripavine series and derived analogs of N-allylnormorphine and -norcodeine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981924-3

Actions of etorphine hydrochloride, (M99): a potent morphine-like agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981924-3

Possible role of distinct morphine and enkephalin receptors in mediating actins of benzomorphan drugs (putative kappa and sigma agonists)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981924-3

After chronic opioid exposure sensory neurons become supersensitive to the excitatory effects of opioid agonists and antagonists as occurs after acute elevation of GM1 ganglioside

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981924-3

Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981924-3

Etorphine elicits anomalous excitatory opioid effects on sensory neurons treated with GM1 ganglioside or pertussis toxin in contrast to its potent inhibitory effects on naive or chronic morphine-treated cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981924-3

Dual regulation by mu, delta and kappa opioid receptor agonists of K+ conductance of DRG neurons and neuroblastoma X DRG neuron hybrid F11 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981924-3

Dihydroetorphine, a potent opioid with low dependent potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981924-3

Etorphine in man. I. Subjective effects and suppression of morphine abstinence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981924-3

Antinociceptive effect of dihydroetorphine in diabetic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981924-3

Characterization of opioid receptors in nervous tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981924-3

3H-etorphine and 3H-diprenorphine receptor binding in vitro and in vivo: differential effect of Na+ and guanylyl imidodiphosphate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981924-3

The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981924-3

Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981924-3

Opioid receptor interaction and adenylyl cyclase inhibition of dihydroetorphine: direct comparison with etorphine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981924-3

In vivo opiate receptor binding of oripavines to mu, delta and kappa sites in rat brain as determined by an ex vivo labeling method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981924-3

Unidirectional non-cross-tolerance (UNCT) in rats and an apparent dissociation between narcotic tolerance and physical dependence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981924-3

Chronic selective activation of excitatory opioid receptor functions in sensory neurons results in opioid 'dependence' without tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981924-3

Antagonists at excitatory opioid receptors on sensory neurons in culture increase potency and specificity of opiate analgesics and attenuate development of tolerance/dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981924-3

Specific N- or C-terminus modified dynorphin and beta-endorphin peptides can selectively block excitatory opioid receptor functions in sensory neurons and unmask potent inhibitory effects of opioid agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981924-3

Antinociceptive effect of dihydroetorphine and its tolerance/dependence liability in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981924-3

Dihydroetorphine is a mu-receptor-selective ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981924-3

10.1016/S0014-2999(97)81924-3

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference